Loading clinical trials...

Implementation of Project YES in Ambulatory Adolescent & Young Adult Medicine | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATIONNA

Implementation of Project YES in Ambulatory Adolescent & Young Adult Medicine

Implementation of Digital Brief, Scalable Single Session Interventions in Specialty Adolescent Care

NCT06359951•Ann & Robert H Lurie Children's Hospital of Chicago

Summary

This study tests a suite of single-session intervention (SSI) targeting risk factors for depression and eating disorders among adolescents and young adults. Youth ages 13-25 who screen positive for depression or anxiety as a part of routine care will be offered one of three digital SSIs. Participants will complete questionnaires before the intervention, immediately after the intervention, and 3-months after completing the intervention so that the study team can investigate if Project YES leads to reductions in depression, anxiety and eating disorder symptoms.

Eligibility

Age

13 - 25 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•a score \>5 on the PHQ-9 OR a score \>5 on the GAD-7
•patient at Lurie Division of Adolescent and Young Adult Medicine
•provider agreement that this would be an appropriate intervention
•age between 13 and 25
•comfort speaking and reading in either English or Spanish

Exclusion Criteria

•inability to speak and understand English or Spanish
•imminent risk for suicide as indicated by a "Yes" response to questions #5 on the Ask Suicide Questions (ASQ) Screener

Locations (1)

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Key Dates

Start Date

August 8, 2024

Primary Completion Date

September 1, 2025

Completion Date

January 31, 2026

Last Updated

May 31, 2025

Enrollment

100

ESTIMATED participants

Conditions

DepressionEating DisordersAnxiety

Interventions

Project YES

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 31, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Implementation of Project YES in Ambulatory Adolescent & Young Adult Medicine

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures